...
首页> 外文期刊>International journal of gynecological pathology: Official journal of the International Society of Gynecological Pathologists >Uterine Tumor Resembling Ovarian Sex Cord Tumor (UTROSCT) Commonly Exhibits Positivity With Sex Cord Markers FOXL2 and SF-1 but Lacks FOXL2 and DICER1 Mutations
【24h】

Uterine Tumor Resembling Ovarian Sex Cord Tumor (UTROSCT) Commonly Exhibits Positivity With Sex Cord Markers FOXL2 and SF-1 but Lacks FOXL2 and DICER1 Mutations

机译:类似于卵巢性索瘤(UTROSCT)的子宫肿瘤通常表现出阳性,其具有性索标记FOXL2和SF-1,但缺乏FOXL2和DICER1突变

获取原文
获取原文并翻译 | 示例
           

摘要

Uterine tumor resembling ovarian sex cord tumor (UTROSCT) is a rare neoplasm which morphologically and immunohistochemically exhibits overlap with an ovarian sex cord tumor. Although many of these neoplasms are positive with markers of ovarian sex cord-stromal tumors, staining is often limited and the pathogenesis of UTROSCT is unknown. To further explore the sex cord lineage of UTROSCT, we studied 19 of these neoplasms and examined the expression of 2 recently described markers of ovarian sex cord-stromal tumors, FOXL2, and steroidogenic factor-1. We also undertook FOXL2 and DICER1 mutation analysis in these cases; a somatic missense mutation in codon C134W (402C --> G) of FOXL2 gene has been demonstrated in the vast majority (> 95%) of ovarian adult granulosa cell tumors and somatic DICER1 mutations are found in approximately 60% of ovarian Sertoli-Leydig cell tumors. Ten of 19 cases (53%) exhibited nuclear immunoreactivity with FOXL2 and 11 of 19 (58%) exhibited nuclear staining with steroidogenic factor-1. Neither FOXL2 nor DICER1 mutations were identified in any case where there was sufficient tumor tissue for analysis (18 and 9 cases, respectively). Despite exhibiting an immunophenotype characteristic of a sex cord-stromal tumor, mutations in FOXL2 and DICER1, the 2 most common mutations hitherto reported in ovarian sex cord-stromal tumors, are not a feature of UTROSCT.
机译:类似于卵巢性索肿瘤的子宫肿瘤(UTROSCT)是一种罕见的肿瘤,其形态学和免疫组织化学表现与卵巢性索肿瘤重叠。尽管这些肿瘤中有许多是带有卵巢性索-间质肿瘤标志物的阳性细胞,但染色通常很有限,UTROSCT的发病机理尚不清楚。为了进一步探索UTROSCT的性索谱系,我们研究了其中的19种肿瘤,并检查了最近描述的2种卵巢性索-间质肿瘤,FOXL2和类固醇生成因子-1标记物的表达。在这些情况下,我们还进行了FOXL2和DICER1突变分析。 FOXL2基因的密码子C134W的体细胞错义突变(402C-> G)已在绝大多数(> 95%)卵巢成年颗粒细胞肿瘤中得到证实,并且体DICER1突变在大约60%的卵巢Sertoli-Leydig中被发现细胞肿瘤。 19例中的10例(53%)与FOXL2表现出核免疫反应,19例中的11例(58%)表现出与类固醇生成因子-1的核染色。在有足够肿瘤组织进行分析的任何情况下(分别为18和9例),均未鉴定到FOXL2和DICER1突变。尽管表现出性索间质肿瘤的免疫表型特征,但迄今为止,卵巢性索间质肿瘤中报道的2种最常见的突变FOXL2和DICER1中的突变并不是UTROSCT的特征。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号